Ultimovacs Completes Patient Recruitment in INITIUM Phase II Trial of UV1 in Malignant Melanoma

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Norway ,Oslo ,Mary Ann Chang , ,Ultimovac Phase ,Carlos De Sousa ,Chief Executive Officer ,Chief Medical Officer ,Fast Track ,Orphan Drug ,Ann Chang ,Lifesci Advisors ,Health ,Business ,Europe ,Cancer ,Clinical Trials ,Melanoma ,Globe Newswire ,